It is currently Tue Jul 28, 2015 7:51 pm

News News of Campath (Lemtrada, Alemtuzumab)

Site map of Campath (Lemtrada, Alemtuzumab) » Forum : Campath (Lemtrada, Alemtuzumab)

A board to discuss the soon-to-be released drug Campath as a treatment for Multiple Sclerosis

second day of campath 3/18/2008

well... me and one of my best friends of 12 years both happened to get diagnosed with MS within a year of each other. We both picked the same neurologist and we both happened to make it to the phase three campath study.

The study qualification was intense.. lots of poking, prodding, degrading testing, and blood work. but we made it.

I wasn't sure up until the last minute that I was going to do ...
Read more : second day of campath 3/18/2008 | Views : 2937 | Replies : 10


Research article

A research article on Campath - but not from the Cambridge team overeeing the trials.

<shortened url>
Read more : Research article | Views : 1811 | Replies : 0


Campax vs Tysbri

My physician provided me two options for treatment Tysbri and Campath. One FDA approved and the other not. One covered by ins and the other possibly not. When I asked my physician which one he would choose for his family member if they were in my shoes he chose Campath.
Are there any reports compairing Campath and Tysbri?
Read more : Campax vs Tysbri | Views : 3747 | Replies : 2


Anyone's insurance paid for Campath outside of a trile?

My Doctor has prescribed Campath in order to stabilize my MS? I have heard of only a few insurances that have paid for the treatment since it is not FDA approved at this point.
If your insurance did approve Campath how did you do it?
If your insurance did not approve Campath, how much were you out of pocket per year?
Read more : Anyone's insurance paid for Campath outside of a trile? | Views : 2118 | Replies : 2


User's experience update

Hi

I haven't posted on here for quite a while. I can't quite believe that it's been 4 years since I posted. Campath seems to have come a long way since then, but has a little further to go. I understand that if all goes well with Phase III, it might be approved in 2011-12.

If anyone is still following my MS story, I've updated the site again recently.
I also notice that I originally ...
Read more : User's experience update | Views : 2292 | Replies : 2


ITP autoimmune disease treatment found

ITP is a serious sideffect that can occure during Campath treatment.
Sciencedaily

--Frank
Read more : ITP autoimmune disease treatment found | Views : 2290 | Replies : 1


Receiving Campath before it is approved for ms?

I may be mistaken but I think I heard of some people being prescribed Rituxan in the past to treat their ms even if it hasn't been officially approved for ms yet. I know that Campath can have some pretty serious potential side effects. My question is; do you think someone could ever be able to receive a prescription for Campath before it is officially approved for ms?


I do not qualify to be in ...
Read more : Receiving Campath before it is approved for ms? | Views : 2239 | Replies : 2


Teen getting Campath

Dear all,

I am currently in southern Spain for a long weekend. Weather is lovely c. 22C / 75F. Sitting on the beach reading my newspaper this morning I see the following story about Campath. I hope this young woman sees the good results I have seen.

http://www.mirror.co.uk/news/topstories ... -20054853/

I´m thinking of you all in freezing cold north America (with the exception of Lori in Florida).

Just think ...
Read more : Teen getting Campath | Views : 1985 | Replies : 0


Campath results at ECTRIMS

A couple of Campath results reported at ECTRIMS. I think there will be some more, but the abstracts are not yet available.

<shortened url>

<shortened url>
Read more : Campath results at ECTRIMS | Views : 8317 | Replies : 31


Phase III trials start

Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis 26 September 2007

Genzyme Corporation and Bayer Schering Pharma AG, Germany today announced that the first patient has been treated in the first of two planned Phase 3 trials examining the safety and efficacy of alemtuzumab for the treatment of multiple sclerosis (MS).

The CARE-MS I trial (Comparison of Alemtuzumab and Rebif Efficacy in ...
Read more : Phase III trials start | Views : 2577 | Replies : 5


 

Login  •  Register


Statistics

Total posts 226652 • Total topics 23874 • Total members 15146


Contact us | Terms of Service